Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.
Hosted on MSN
THIS forgotten gout drug could hold the key to prevent heart attacks and strokes; offering hope to millions at risk
In recent years, scientists have increasingly turned their attention to older, affordable drugs to explore whether they offer benefits beyond their original purpose. Colchicine, a cheap and widely ...
Patients with gout are commonly prescribed colchicine prophylaxis, despite already taking medications that could potentially interact. Patients with gout are commonly prescribed colchicine prophylaxis ...
(Boston)—Gout is the most common form of inflammatory arthritis, with worldwide prevalence of approximately four%. The accumulation of monosodium urate crystals in gout leads to the clinical ...
NEW YORK CITY — Urate, the culprit of gout, affects the vasculature in multiple ways that can raise cardiovascular risk (CV) in an individual with gout, and following guidelines for gout treatment, ...
Scilex Holding said the Food and Drug Administration granted orphan drug designation for colchicine for the treatment of pericarditis. The company's Gloperba, licensed from Romeg Therapeutics, is a ...
Scilex Holding Company announced an amendment to its license agreement with Romeg Therapeutics for Gloperba®, the first and only liquid oral formulation of colchicine, indicated for preventing painful ...
In patients with gout starting allopurinol as a long-term urate-lowering therapy, the prophylactic use of nonsteroidal anti-inflammatory drugs (NSAIDs) was associated with a higher risk for major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results